Generic Name and Formulations:
Thiamine 1.5mg, riboflavin 1.6mg, niacinamide 17mg, pantothenic acid 10mg, pyridoxine 50mg, folic acid 1mg, Vit. B12 12mcg, biotin 30mcg, Vit. D3 400 IU, Vit. E 10 IU, iodine (as potassium iodide) 175mcg, iron (polysaccharide iron complex 22mg + heme iron polypeptide as Proferrin 6mg), copper (as cupric sulfate) 0.8mg, selenium (as sodium selenate) 65mcg, zinc (as oxide) 15mg; tabs.
Indications for PreferaOB:
Nutritional supplement during pregnancy, prenatal, and postnatal periods.
1 tab daily.
Wilson's disease. Hemochromatosis. Treatment of pernicious or other megaloblastic anemias.
Folic acid may mask pernicious anemia. DHA: bleeding diatheses.
Iron blocks tetracycline absorption. Antagonizes levodopa. DHA: avoid anticoagulants.
PreferaOB—90; PreferaOB + DHA (30 tabs + 30 softgels)—60; PreferaOB ONE—30
Sign Up for Free e-newsletters
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Melanoma Outcomes Improved With Nivolumab Alone or Plus Ipilimumab
- Oral Contraceptive Use May Not Be Associated With Increased Melanoma Risk
- The Caregivers' Cancer Journey
- Staff Education Leads to Increase in Oncology Rehabilitation Referrals
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Choice of Breast Reconstruction After Mastectomy Affects Satisfaction, Quality of Life
- Gender Bias in Medicine Has Far-Reaching Consequences
- Carfilzomib Benefits May Outweigh Cardiovascular Risk in Multiple Myeloma
- Patient Interest in Melanoma Genetic Risk Testing is Fairly High
- Genetic Link Between Depression and Breast Cancer Remains Unclear
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|